SMTL ID : 6hd4.1 (1 other biounit)

ABL1 IN COMPLEX WITH COMPOUND 7 AND IMATINIB (STI-571)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.03 Å

Oligo State

monomer

Ligands

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 4 residues within 4Å: Chain A: Y.98, Y.104, E.112, H.153 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Y.104 Water bridges: A:E.112, A:E.112

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 3 residues within 4Å: Chain A: F.137, I.138 Ligands: STI.4 Ligand excluded by PLIP

1 x FYW: 6-[(3~{R})-3-oxidanylpyrrolidin-1-yl]-5-pyrimidin-5-yl-~{N}-[4-(trifluoromethyloxy)phenyl]pyridine-3-carboxamide(Non-covalent)

FYW.3: 19 residues within 4Å: Chain A: R.110, A.115, L.118, L.119, A.122, L.207, I.210, A.211, T.212, Y.213, M.215, E.240, C.242, P.243, V.246, F.271, I.280, V.284, L.288 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:A.115, A:L.118, A:A.211, A:Y.213, A:I.280, A:V.284 Hydrogen bonds: A:R.110, A:A.211 Water bridges: A:R.110, A:R.110, A:E.240, A:E.240

1 x STI: 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE(Non-covalent)

STI.4: 22 residues within 4Å: Chain A: Y.31, V.34, A.47, V.48, K.49, E.64, V.67, M.68, I.71, V.77, I.91, T.93, F.95, M.96, G.99, I.138, H.139, L.148, A.158, D.159, F.160 Ligands: CL.2 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:Y.31, A:V.34, A:A.47, A:K.49, A:E.64, A:I.71, A:I.91, A:T.93, A:L.148, A:D.159, A:F.160 Hydrogen bonds: A:E.64, A:T.93, A:M.96, A:D.159 pi-Stacking: A:Y.31

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schoepfer, J. et al., Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1. J. Med. Chem. (2018)

Release Date

2018-10-24

Peptides

Tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase ABL1

Related Entries With Identical Sequence